Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Serini, G., Napione, L., Arese, M
This article was previously distributed in the August 22, 2023, educational email of the Patient Safety Authority, available at About the Author Patient Safety Authority (patientsafety.pa.gov) is an independent state agency that oversees the Pennsylvania Patient Safety Reporting System (PA-PSRS), the largest database of its kind in the United States.
n vi SIME BEAUTY th khch hng s c mua vi mc gi u i
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
US$ 27.28
US$ 20.78
US$ 25.36
US$ 23.46
US$ 28.90
